TOKYO–(BUSINESS WIRE)–R-Tech Ueno (JASDAQ:4573) This is to announce that R-Tech Ueno, Ltd. (Head Office: Chiyoda-ku, Tokyo, CEO and President: Yukihiko Mashima, hereinafter referred to as “R-Tech Ueno”) has acquired the right to develop and commercia…
Author: Business Wire
Acucela Provides Important Company Updates
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, tod…
Aerie Pharmaceuticals Reports Initial RhopressaTM Phase 3 Efficacy Results
IRVINE, Calif. & BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today reported the results of its first Phase 3 registration trial (Rocket 1) for RhopressaTM, a novel once-daily, triple-action eye drop being tested for its ability to
Prestige Brands Announces Ron Lombardi to Succeed Matt Mannelly as President and Chief Executive Officer
TARRYTOWN, N.Y.–(BUSINESS WIRE)–Prestige Brands Holdings, Inc. (NYSE:PBH) announced today that Matthew M. Mannelly, President and Chief Executive Officer and member of the Board of Directors, will retire effective June 1, 2015. Following his retirement, the Board of Directors has appointed Ron Lombardi, Chief Financial Officer, to succeed Mr. Mannelly as President and Chief Executive Officer. The company has commenced a search for a new Chief Financial Officer. “Ron and Matt have worked toget
Clearside Biomedical, Inc. Announces Purchase of iScience Patent Portfolio for Suprachoroidal Space Drug Delivery
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, which develops drug therapies to treat eye diseases, announces acquisition of iScience Interventional Corp.’s patent portfolio covering drug delivery to the suprachoroidal space.
Research and Markets: Global and Chinese Visual Chart Monitor Industry, 2010-2020 Market Research Report
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/kjmvvr/global_and) has announced the addition of the “Global and Chinese Visual chart monitor Industry, 2010-2020 Market Research Report” report to their offering…
II-VI Optical Systems to Debut Most Recent Capabilities Integration at the 2015 SPIE-DSS Show
MURRIETA, Calif.–(BUSINESS WIRE)–II-VI Optical Systems (II-VI OS) will present at the SPIE-DSS show in Baltimore Maryland, April 20-23, 2015, Booth #725.
Eleven Biotherapeutics to Report First Quarter 2015 Financial Results on April 30, 2015
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven Biotherapeutics to Report First Quarter 2015 Financial Results on April 30, 2015
Presbia Announces the Start of Commercialization of the Presbia Flexivue Micolens™ in Australia
DUBLIN–(BUSINESS WIRE)–Presbia Announces the Start of Commercialization of the Presbia Flexivue Micolens™ in Australia
Anthem, Inc. Offers Six Tips for Maintaining Healthy Eyes in Recognition of Women’s Eye Health and Safety Month
INDIANAPOLIS–(BUSINESS WIRE)–Anthem, Inc., offers six tips for maintaining healthy eyes in recognition of Women’s Eye Health and Safety Month.
Technavio Publishes Market Forecast and Analysis on the Smart Glasses Market for Augmented Reality 2015-2019
LONDON–(BUSINESS WIRE)–Technavio has published a new report on the smart glasses market for augmented reality (AR), which is expected to grow at a CAGR 194.2% from 2015-2019.
Icon Bioscience Announces Pivotal Phase 3 Clinical Data Demonstrates Exceptional Efficacy of IBI-10090 in Reducing Inflammation Associated with Cataract Surgery
SUNNYVALE, Calif.–(BUSINESS WIRE)–Phase 3 trial data showed that IBI-10090 is highly effective in treating inflammation post cataract surgery.
Meeting the Needs of Ophthalmologists: ZEISS Showcases Integrated Solutions that Deliver Faster Practice and Surgical Workflow and Address Critical Diagnostic Challenges
SAN DIEGO & DUBLIN, Calif. & JENA, Germany–(BUSINESS WIRE)–Meeting the Needs of Ophthalmologists: at ASCRS 2015, ZEISS Showcases Integrated Solutions that Deliver Faster Practice and Surgical Workflow and Address Critical Diagnostic Challenges
Modernizing Medicine Showcases New Mobile EMA Ophthalmology EMR System at the American Society of Cataract & Refractive Surgery Annual Symposium 2015
BOCA RATON, Fla.–(BUSINESS WIRE)–Modernizing Medicine the creator of the Electronic Medical Assistant® (EMA™) will showcase the latest advancements with EMA Ophthalmology® at this year’s ASCRS annual symposium.
Ivantis Completes Enrollment in Pivotal HYDRUS IV Glaucoma Study of the Hydrus™ Microstent
IRVINE, Calif.–(BUSINESS WIRE)–Ivantis Completes Enrollment in Pivotal HYDRUS IV Glaucoma Study of the Hydrus™ Microstent; Clinical Milestone is Major Step Forward to FDA Review of Innovative and Less Invasive Glaucoma Technology
Clarity Medical’s RetCam Will Be Used in a Worldwide Clinical Study for the Treatment of Premature Infant Ocular Disease
PLEASANTON, Calif.–(BUSINESS WIRE)–Clarity Medical Systems, Inc., a developer and marketer of ophthalmic diagnostic imaging technologies, is pleased to announce that their product, RetCam, will be utilized to image premature infant eyes in a study to evaluate a potential new method for treating Retinopathy of Prematurity (ROP) using Lucentis™ (ranibizumab). “The use of RetCam in a study of this medical significance demonstrates the growing worldwide acceptance of RetCam for pediatric retinal
Visioneering Technologies, Inc., Introduces NaturalVue™ 1 Day Multifocal Contact Lens Works with the Brain to Optimize Vision
ALPHARETTA, Ga.–(BUSINESS WIRE)–Visioneering Technologies, Inc. (VTI), based in Alpharetta, GA, has announced the launch of NaturalVue™ Multifocal 1 Day daily disposable contact lens that solves the needs of those with presbyopia.
pSivida VP of Research to Discuss Company’s Protein and Antibody Sustained Delivery System at 5th Ocular Diseases and Drug Development Conference
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida VP of Research to discuss company’s protein and antibody sustained delivery system at upcoming Ocular diseases and drug conference
Customer Survey Shows High Satisfaction Rate with ReVision Optics’ Near Vision Inlay for Presbyopia
LAKE FOREST, Calif.–(BUSINESS WIRE)–ReVision Optics®, Inc. (RVO), a leader in implantable inlay technology to treat presbyopia, reported a high level of satisfaction from a group of 58 patients treated for presbyopia at the Ultralase Clinics in the …
Sprint Launches Code Factory Mobile Accessibility Application for Free to Android Users Who Are Blind or Have Low Vision
SAN DIEGO–(BUSINESS WIRE)–Free app is now available, making Android smartphones more accessible for postpaid and no-contract Sprint customers